The Latest SPAC News and Rumors: July 7, 2021
by Marlena Haddad on 2021-07-07 at 11:34am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Novo Tellus Capital mulls Singapore SPAC, Virala SPAC seeks to fill gap left by underfunded Finnish PE, and Dragoneer, Altimeter eye raising new funds


Novo Tellus Capital Mulls Joining Singapore SPAC Race

Singapore buyout firm Novo Tellus Capital Partners is considering setting up a SPAC to list in the city-state as regulators prepare to authorize the vehicles in the local market.

The private equity firm, which focuses on technology and industrials, has had preliminary discussions with banks.

READ

Virala SPAC Seeks to Fill Gap Left by Cash-Strapped PE

Finland’s first SPAC says it plays a unique role in providing especially fast access to capital, given the limited resources private-equity investors have in the Nordic nation.

Virala Acquisition Company Oyj last month raised 107.5 million euros ($127 million) from investors in an IPO in Helsinki, and now has three years to find a mid-cap company to acquire. The company intends to give its target a quick way to fund growth as a public company and avoid having to sell to an industrial buyer, typically foreign, for lack of other options.

READ

Dragoneer, Altimeter Look to New Funds as Unicorns Burgeon 

Marc Stad’s Dragoneer Investment Group and Brad Gerstner’s Altimeter Capital Management are each seeking to raise new vehicles focused on backing fast-growing technology companies.

Dragoneer is in talks to raise $2.5 billion and Altimeter has targeted $1 billion for bets on startups. The firms are looking to draw the attention of limited partners such as pension funds, sovereign wealth funds and family offices.

READ

Malaysia’s AirAsia Aims to Raise $300M Through U.S. Listing of Digital Business

Malaysia’s budget airline AirAsia Group Bhd is considering listing its digital arm via a SPAC in the United States to raise at least $300 million, its chief said on Wednesday.

Group Chief Executive Tony Fernandes told Reuters in an interview that a few SPACs focused on technology have approached the group, and AirAsia has engaged auditors for the deal.

READ

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved